No evidence for additional systemic eosinophil mobilization during exacerbations in patients with COPD and chronic bronchitis but no allergy
BackgroundThere is published evidence that a modest increase in blood eosinophils during stable COPD indicates future risk for exacerbations and a potential utility of inhaled corticosteroids. This has been perceived as an argument for targeting systemic eosinophil mobilization to prevent exacerbati...
Saved in:
| Main Authors: | Anders Andersson, Kristina Andelid, Bettina Brundin, Ann Ekberg-Jansson, Anders Lindén |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-05-01
|
| Series: | Frontiers in Medicine |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fmed.2025.1572291/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Biomarkers of type 2 and non-type 2 inflammation in asthma exacerbations
by: Kosar M. Ali, et al.
Published: (2024-07-01) -
Variability of blood eosinophil count and prognosis of COPD exacerbations
by: Sandra Martínez-Gestoso, et al.
Published: (2021-01-01) -
Clinical Characteristics and Outcomes of Eosinophilic Exacerbations of COPD
by: Donnan M, et al.
Published: (2025-04-01) -
COPD exacerbation: factors influencing hospitalization duration
by: Gashynova K.Yu.
Published: (2015-03-01) -
Eosinophil count and treatment response in COPD patients
by: CR Kiran, et al.
Published: (2025-07-01)